| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 83,860 | 81,293 | 67,756 | 96,892 | | Cost of Revenue | 47,781 | 47,746 | 42,371 | 48,686 | | | Gross Profit | 36,079 | 33,547 | 25,385 | 48,206 | | | Operating Expenses | | Research Development | 15,879 | 15,450 | 14,496 | 14,207 | | Selling General and Administrative | 19,405 | 20,736 | 21,290 | 26,393 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,367 | 1,533 | 389 | 160 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (572) | (4,172) | (10,790) | 7,446 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 372 | 635 | 864 | 1,138 | | Earnings Before Interest And Taxes | (200) | (3,537) | (9,926) | 8,584 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (200) | (3,537) | (9,926) | 8,584 | | Income Tax Expense | (2,777) | 4,383 | 8,917 | (4,625) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,577 | (7,920) | (18,843) | 13,209 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,577 | (7,920) | (18,843) | 13,209 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,577 | ($7,920) | ($18,843) | $13,209 |
|
0.51% Nasdaq 
0.20 (3.11%) 
Income Statement
